Are Quest Laboratories Ltd latest results good or bad?

3 hours ago
share
Share Via
Quest Laboratories Ltd's latest results show strong revenue growth of 68% year-on-year, but profitability has declined significantly, with net profit down 33.66% and operating margins sharply reduced. While the company has a solid return on equity and a strong cash position, concerns about the sustainability of its growth and profitability remain.
Quest Laboratories Ltd's latest financial results for Q2 FY26 reflect a complex operational landscape characterized by significant revenue growth alongside challenges in profitability. The company reported net sales of ₹25.62 crores, marking a year-on-year increase of 68.00% and a sequential growth of 10.53%. This strong topline performance indicates the company's ability to expand its market presence and product offerings.
However, this revenue growth is juxtaposed with a notable decline in profitability metrics. The net profit for the quarter was ₹4.02 crores, which represents a year-on-year decrease of 33.66% and a slight quarter-on-quarter decline of 1.95%. Furthermore, the operating margin has contracted sharply to 13.23%, down from 32.15% in the same quarter last year, reflecting a compression of 18.92 percentage points. This margin erosion suggests that rising costs or pricing pressures may be impacting the company's ability to maintain profitability despite higher sales. Additionally, the contribution of other income to profit before tax was significant, accounting for 35.32%, which raises concerns about the sustainability of core business profitability. The tax rate anomaly, with a reported zero tax expense for the quarter, further complicates the financial picture, as it lacks transparency regarding the underlying reasons. Despite these challenges, Quest Laboratories maintains a strong return on equity (ROE) of 25.90%, indicating effective capital deployment relative to shareholder equity. The company also holds a net cash position, with a negative debt-to-equity ratio of -0.19, providing financial flexibility. In summary, while Quest Laboratories has demonstrated robust revenue growth, the substantial decline in profitability and operational margins raises questions about the sustainability of this growth trajectory. The company has experienced an adjustment in its evaluation, reflecting the mixed signals from its financial performance. Investors may need to monitor the company's ability to stabilize margins and improve core profitability moving forward.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Quest Laboratories Ltd is Rated Hold
Feb 08 2026 10:10 AM IST
share
Share Via
Quest Laboratories Ltd is Rated Hold
Jan 28 2026 10:10 AM IST
share
Share Via
Why is Quest Laboratories Ltd falling/rising?
Jan 24 2026 01:01 AM IST
share
Share Via
Quest Laboratories Ltd is Rated Sell
Jan 05 2026 10:15 AM IST
share
Share Via
Quest Laboratories Ltd is Rated Sell
Dec 25 2025 12:58 PM IST
share
Share Via